Inventiva S.A. (IVA)
NASDAQ: IVA
· Real-Time Price · USD
4.50
0.14 (3.21%)
At close: Aug 18, 2025, 3:59 PM
4.48
-0.44%
After-hours: Aug 18, 2025, 04:00 PM EDT
3.21% (1D)
| Bid | 3.84 |
| Market Cap | 268.74M |
| Revenue (ttm) | 9.2M |
| Net Income (ttm) | -184.21M |
| EPS (ttm) | -3.61 |
| PE Ratio (ttm) | -1.25 |
| Forward PE | -4.26 |
| Analyst | Buy |
| Ask | 4.72 |
| Volume | 39,599 |
| Avg. Volume (20D) | 23,440 |
| Open | 4.45 |
| Previous Close | 4.36 |
| Day's Range | 4.28 - 4.64 |
| 52-Week Range | 1.53 - 4.64 |
| Beta | 0.62 |
Analyst Forecast
According to 0 analyst ratings, the average rating for IVA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+0%
Inventiva shares are trading higher after the comp...
Unlock content with
Pro Subscription
5 months ago
+1.11%
Inventiva shares are trading lower. The company announced the initiation of the clinical development program of lanifibranor in Japan with the first Japanese participant dosed in a Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of lanifibranor.
